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Phonyikatonuria» ono of cho horo4itory ootoboile dloooooo, 1«
charocterl&ad by irooo wtntol rotordocion and by incroaaod **t\m
phonylalanina iowia.7® Slneo tha diaeovory of a opaeifie oiuiyaatie
dafaet aa tha cauaa of tha aataholla abarratton* ovar thrao hundrad
dlaordaira ahleh ara probably ganatically datamlnad haaa boon racogaiaad.43
fat# phonyIkatonuria raaalna noat axtanaloaly atudlad, oalnly daa to ita
aaaa in dataetion and tha poaalbla prarantlon of tha aantal da fact if
traatad fram aarly in Ufa.5
At praaant a phanylaianina-raatrictad diat haa proved to ba tha
only therapeutic oaaaura of valaa in waintaiming practically collate
noraaliaation of tho

tabolltaa in aanaa and urine, howavar, thara la

not anfficiont evidanca to parwlt tha coneluoion that aa good xoaulta
can ba achiavad by a partial raductlon of ao:

phanylalanlna lavala to

5 to 10 or 10 to IS ng. par cant aa by a radoctioa to noraal lovala.^5

tha purpoaa of this study (l)
to dstoraina tho aptiaal aamo phanylalanlna lavol in diffarant aga
groups ohlch could facllitata graataat incraaaa or Maintoaanca of
intalliganca, and tha phanylalanlna intake required to naintatn this
lovely and (2) to conpare the growth rates of phonylkotonurie childran
with tha aatabliahad noma.
1

t

Immxtmmm &£

noatol dofieloxiey

Study,

Sxperiaexit* hmm damnstr«tod that

h* ovorted In phonylketomtric elilldrosi and that

thoj eon dovalop noraally if dlotaxry traatnont la atartad aoon aftor
tibaa too diat la a tartad latar in Ufa, altar a car tain
awnint of dawaga has already occurred, the ehanieal wail fas tat loas of
this disorder util diaappaar and the asntai datarioration will ha
arras tad or inprova slightly in aaaa eases hut to a vary ad Id dagraa in
eoaparisen to thma star tod on diet

aftor hirth.^1 Sowavnr, not

is knoon eoneoming tho etiology of the nontax retardation at
peasant to bo too prodietlve regarding the dietary traatnant started
later in life.*****
Ae stated previously, no dofinito concluaion can ha asds. Iron
tha reports available, of the bonaficial affacta with partial reduction
of esma phenylalanine level*.*5 Therefore, it uould ha helpful to
those treating phenylketonuria patients if a study canid he cenductsd
to detemino the level of eorun phonyialenine Which uould result in the
graeteat increase of intelligence or maintenance of normal intelligence.
Subaeituantiy, the dietary phenylalanine required to maintain this optimal
serum level uould need to be

itimated.

In e previous study*5 it was indicated that phanylketomiric
children tend to he ehertar than average normal children* Bouever,
there

no studies reported which Indicate whether those

children treated from birth ere ehertar than normal children.
Limitations

£&& gtudv. Since phonyIks tonuria is a relatively

rare disease, occurring

in 20,000 to 50,000 live births,*5*****5*®2

the population available for this study wee not large, Meet of the non*
institutionalised phonyIketonuric patients in the geuthem California area

%

mem tMiing mm& *t the Whit« Uamtiml Medical Center

thm Childmn'm

Hospital* Most of those pet loots ere usider dietary treatneist* Sloes
a aajority of the severely retarded children are plated la various
state institutions, the group studied included these vbe were started
on treatment comparatively early in Ufa and sere not severely retarded*
Hie accuracy of nutritional histories depended m the degree of
parental cooperation and the exactness of tho person recording then*
Since the parents oho eexe requested to hoop on accurate Intake record
for throe days often failed to do so, a “recall" intake history
used in amsy instances*
In the grooth study seas factors ohich nay offset the growth of
a child were not considered*

the study of ths dstocoination of tha opt Iasi aortas phsnylalanins
level and tha dietary phenylalanine requireaent trill he discussed in
proceeding chapters as fallensf
Usview of rolatod Utoxaturs*
Chapter HI* the asthod used*
Chapter If* lesults and discussion*
Conclusl^is*

m* staasaity
In this chapter etteapts were aede to deserihe the pxohlea
discussed In the fol lowing shspters end to give an overall organisation
of tho reaalodor of tho thesis*

tomm or tbs urmsm
Huch research has baan raparssB in recent years in the field
ef hereditary oetabellc diseases» especially phenylketonuria; however,
only a short susnery of phanylhetosturla and those findings relevant to
this disease will ha presented hare*
U

HISTORY

Phenylketonuria was first brought to the attention of the
osdical profeseion in 1934 by a Homeglan physician and hioehaaiat*
Hr, Aabjom foilingt who diagnosed the dlsasso is two asntaiiy rscarded
eibiinge* These children^ at tha ages of four and seven yam* had
ha«ci brought to Br* falling hy their ebeervant nether

their

peculiar clinging odor which eat then apart fron others.16
mule teeting the tsrine of tbaee children for dl«

itic cold

with ferric chloride* Or. felling discovered that a green eeler occurred
instead of the expected red-brown color. Bo then tot out to dotoxnino
this unknown subs tone# in tbs urino. He subaeguently succeeded in
isolating and Identifying it aa phanylpyruvic acid. Within a few wraths
altar tha first phenylketonuria children were brought to bin* he diecovered eight were cases sad published e scholarly report on thie
new nstaholic disease* which he called “isfcecilitas phenyipyruvica”.15*16
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IMLMHCE AXm immitMCE

Sine® £b® concept of s*iaborn error* of me rebel i®jan was intro
duced by Sir Archibald Oarrod in 1908tbs discovery of disease*
which can be attributed to genetic defects has greatly increased* this
Increased knowledge

from the availability of more accurate methods

of research, such as chrosiatography» electrophoresis and histociiemistry,
which permit identification of chemical entitles In the tissues, body
fluids or excreta of individuals being studied.**
Although accurate knowledge of incidence is not available, it
is estimated that phenylketonuria occurs once in 20,000 to 50,000 live
births in the general population*^*?**?5*®* As a result of studies
of patients In institutions, it has been estimated that % to l per cent
of such patients are affected.®**5 Phenylketonuria appears to occur
more frequently among people of northern European origin182 and rarely
among Negroes and Jews.^5
l

This rare disease is transmitted by a single Mendelian autos
recessive gene* Therefore, in order for a child to be affected, both
parents must be heterosygous for the disease.^5*5® Although each new
born has only a 1:4 chance of being affected, surveys of the involved
families show a much higher ratio of phenylketonuria children.5^ Both
saxes are equally affected.®5
To add a new challenge to the autosomal gene theory, Allen and
Gibson recently reported an interesting case in which a phenylketonuria
child with normal intelligence was born to a heterosygous father and a

non-carrier mother. They hypothesised that this might be a heterosygous
case In which the recessive gene had stronger penetrance than usual.

*9

6

axirccAL nmim$
^ ■•jority of ttncrootod yhonylkstonorle
potlonto oxo of vory iowgrodo intolUgoneo* Studios of tbooo pot lento
indicate that about S3 pat cent have an £•<!• of below 21, 36 pet cent
between 21 and 70f and only about i pet cent have an X,Q» above 70*27
fbete have been several Isolated reports of untreated patients with norwsl
or neat notnel intelligence,47*80 and others with nomal intelligence
but with behavior problews which were corrected by a phenylalanine-restricted
diet.84*88 ?epla and fischlar and cowsrhers reported independently of
two untreated patients with norDial intelligence who had phanylhatemiric
siblings with very low nental status*88*88 Another intereetlng cese of
e phenylketonuria woasn with two nontelly retarded children who were not
phonyIkotonurtcs has been reported by Denniston*81
Children effected with phe^rlhetenuria appear to ha nomel at
birth.

at about 4 wonths of ago they begin to loan their abilities

and internet, and beeswe rapidly worse in the following year.15*78 Most
of thoso children do not welk nor talk until 2 to 2% years sad 3 to 4
years respectively* Sons never learn te talk nor walk.*5
It la comma aaeitg the lew-grade phenylketonuria children to
annlfest "psychotic behavior, in the fom of eovere hyporectlvity, end
uncontrollebie attacks of rage***45 In the higher grade, behavior
frequently seen is "schlsephrsnic-like msalfss tat ions such as hallueinstions, seclusiveness, and usqpredictable behavior with episodes of
excltonsnts***45

7
llus%yydy>l&* Varioa# neurologic neni fee tat lone
aro ceomxily praeant in untreated pbenylketonuriee. Hera than half of
the patient# exenined ahoued an apparent increaee In naecle tona9
a# wuscular rigidity 9 trenort hyperre He xia, repetitive purposeless
novemta of the idmia ho# or aoae aegaanta of the ho#,45*54 In
another study, aiaoat $0 par cant of the patients had Shnornal electro*
eneephalograao

In ahout 25 per cent there oaa a history of convulsions

or aoiatsrea of grand eel type*54 these ahnomsUtisa appear to ha sore
in Infancy and childhood,45 Microcephaly45*54 and
donyelinetion

hrain57*45*75 often appear aneng the petienta with

very loo Intel ligence. In eonj

ition with the neurological ahnoraalltlea

nantlonad ahova, it la of Interest to note that Bacmn
f*m4 in thair study that the asureiegleal ayuptosHi paralleled results
of intelligence testings,7
&$£&KS£fiL tnifaatationa. One of the neat cannon nanifestations
fomid in the untreated phenylketonuria pet lent la the peculiar odor,
described ae being a nuaty, horsey odor, which

he duplicated by

phenylaeatlc acid, the nejority of the petienta have a tendency for
biondnaaa with approninatoly fid per cent being nore blond then thair
parents or nomal siblings,15»45
Although vonitlng la ve^r coonon anoog untreated infanta, it
is not gonarally recognised as a aynpten of phanyikatonuria,57 On the
other hand, acaonatous conditions of the skin occur in a c^nsidurable
percentage of caeoe, eatineted between 20 to 40 per cent in infancy,45*75
Falnberg
petienta, which

Fish report ahnonsai long bona growth la 5 young
ilstod of Hcalclfiad apiculoa of cartilage projecting

a
into the eplphysaal certiiaga £xtm thft zom of the distal meaphysls
of growing long bona ’.23

Brown and coworkers found In their study

occasional abmmakl bata*globulin in the serum of phenyIketonur 1c
children*15

Both of these conditions mx% reversed by a pheinyl&ianina-

rastrieted diet*

xv*

biochemical

Hor^al nhenylaiaaine ssifcaboUsm.

nmims
In the normal individual with

Intact metabolism, phenylalanine is rapidly hydroxylatad In the liver
to tyrosine, which in turn is metabolized to aelanine, norapitiephrin®,
epinephrine, thyroxine, and fumaric acid and acatoacatic acid through
homogentisic acid*1^*^ Hormlly, phony Ipyruvic acid and phenyl lactic
acid ate converted back to phenylalanine and then metabolised through
tyrosine through homogentisle aeid,^ this irreversible hydroxylation
of phenylalanine is catalyzed by two enzymes, Znzyate X present only in
the liver and Enzyme IX found in almost all tissues•58,49,71 other
chemical substances required for this reaction are Og, Fe4'--, T?HH, mid
a pteridlne«like cofactor*14*76 Results of experiments indicate that
Snzysae X and fcatrahydropteridtn® are directly involved in the conversion
of phenylalanine to tyrosine, whereas Sftsyna IX catalyzes a reaction,
involving TOU, which serves to keep the totrahydr<^>teridine in the
reduced active
The normal pathway for phenylalanine

taboli

is outlined in

Figure l, page 9.

Mmsmk gMhzMmte iiaagUm M BkmxJMmmzM' J*xvt*$
in 1947, discovered the defect in phenylketonuria to be a block in the
conversion of phenylalanine to tyrosine,4*27 As a result of this defect
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piMmyiketoautfia p«tlonts Bksm hi$k

lavala of phanylalanina

(tip to 90 «g* pot 100 tol. «• eoopozo4 to a ooraal of 1*2 am* par
100 nl«) and low lavala of tyroaiaa (balow 1 ag* par 100 al« as
eoaparad to a ooraal of 1*2 ag. par 100 al.)*82 Althoogik thara bare
boon raporta of aoao oxidation of pbanylalaalna with an ansyaatie
preparation froa tha phanyllcatonitrla llvar, It can be
there la a coop lata loaa of ability la phenylfca*

ildarad that

la to oaldlaa

phony* ***? no
It baa boon pravioualy diaasaaad that for hydroxylatlon of
pbanylalanlna to tyroalno two anayaaa are required,
in the Hoar

I found only

Saayaa IX praaant in all tlaaoaa. Uallaea and to*

norkara daaonatratad that tha edition of

I froa tha rat liner

activated tha eonvaralon of phanylalanina to tyroalno with otherviee
jj49t71 ^4 m
inactive phenylketonuria liver honofaeata*28
pterldine«like cofaotor^8 appear to ho present in phenylketonuria
liver eeuplee In nonaal oaeunto. ffaise* in phesylketonurie» the bio*
cheaieel defect oppeora to bo the inability to fora o specific estsyoe
only in liver for the oxidation of phenylalanine • **
the deficiency In the foraatl*

of tyrseine

the inereaea in

eorua phenylelenitie end ita derivatives result in aaay aatabolic
altarotiona* |jg vitro L*pheayiolenine la chiefly reeponalble for
redticod plgaentatlon* trhereec phectylpyruvate ic lees affective*^8 It
has bean ahoun that phenylaianina can intarfara with tha aneyae tyroeinaee
which ia involved in tha foraation of aaloaina*7^ There ore decreased
aaounta of norepinephrine end epinephrine In the plesaa end urine of
phenylketonuria children* A urinary decrease of dopoaina has aloe been
noted* Reveraebility of these ahnoxaolltioa with the phenylalanine*

u
restricted diet* even though piasas tyrosine levels renein the MB*
eppeers to indicete the toxicity of iocreesed enounts of phenyleleiiixie
vs its derivetives.52 Using rot liner slices Boylea end Quests! showed
that sodiue phenylpyrunste decreosed epinephrine synthesist however, the
edition of L-pheayleleniae hod no effect**2
In addition to pfaenylolonine, phenylpyruvic acid, phenyllaetlc
acid and phenylaeetic acid, the urine of phenylhatMsric children
taiaed increaeed aeounta of ortho-hydroiiypheiiylacetlc acid, para*

the

promote of tyrosine neteholieo under nonwl conations* Since

the foraetion of tyroeine ie iepalred in phenylketonuria, it msat ho
MaiMed thet these euhetssicee ace the hydtesqrlatioa products of
phsnyllactlc ecld end phenylaeetic acid*92
tha ability of phonyIketonuries to hydroiqrlatc other aronatic
ccsBounde ie not effoctod*72

•Edition to axnosnol phoaylalanino netahollsfli, elteretioae in the
netehelien of eoveral other net arectly routed suhstencee have
observed in phenyIke toneris. Since these altereti*

assppear with the

adninistratlon of a phenylalanine restricted diet, it is —warn* that
they era aacsndary to the aacuMtlatloa of phenylalanine or its derivatives
which interfere with nomel netebolion*92
da increased urinary excretion of indolalactic acid and in*
doleacetic acid, aa well as a lowered eeruw serotonin and other
hydroxyleted derivatl

of tryptophan show that a disturbance of

tryptophan nstahollen la aMociatad with phanylkatBwria*2*29*22*®2

12
Studies have indicated that the levels of plaane serotonin of un*
controlled patients is lower than that of controlled phony Ike tonuric
patients
Increased administration of phenylalanine decreased the brain
serotonin content in both humans and rats#^*2b,74,82 whereas excess
tyrosine intake had no effect, end as expected, exceee tryptophan in*
creased serotonin content of liver end brain.7* Phenylalanine has been
reported to inhibit the uptake of 5-hydroxytryptophen, a serotonin
precursor, into the brain, and its metabolitaa ara observed to inhibit
both glutsmlc acid end 5-hydroxytryptophan dihydroxyphenylalenine
decarboxylase.8^ Zellweger hypothesised that if email amounts of
hydroxylase were present in phenylketonuria, yet insufficient to
hydroxylato both phenylalanine and tryptophan, than daersaaad hydroxy la ted
products of both auhataneoa will roault. Therefore, if a phenylalanine
restricted diet is instituted, the email amount of hydroxylase present
may suffice for the conversion of tryptophan to its hydroxylated com-

The alterations of metabolism of phenylalanine and ralatad
substances is phenylketonuria ara outlined la figure 2, page 13.

EfrjjtUtto mskmL £l && MmplmtMk &£&&*

****••

of the neurologlcel defect which elmoet Invariebly develops in children
affected by phenylketonuria ara still unknown,

la this section toms

of the hypotheses reported in the literature will be reviewed.
Tsshlan reports that there is evidence that gamma-aminobutyric
acid, which la formed in memaallaa brain by ensymatic decarboxylation
of l»-glutanic acid, may play an important rola in cerebral function

14
regulation axi4 davelofmnt.

It this It true, any interference with

gaana-aaiinobutyric acid tyntheeit in the developing brain could result
in brain danege.

Using rat brain homogenate Tashian demonstrated that

phenylalanine derivatives, ortho«hydroxyphenylacetlc acid and para*
hydroxyphenylace tic acid, effectively inhibited the activity of glutamic
acid decarboxylase.

It is suggested that if thsse phenylalanine

derivatives sere formed in excessive amounts and reached the developing
brain, thay could aupproaa the formation of gemwa aminobutyric acid and
otbar amines which msy he ssssntial to normsl neurologlcsl development
end function.
the inhibition of ojqrgen consumption in the brsin mey be another
factor contributing to tbo neurological dafact In tba phenylhetonuric
children, the oxygen consult ion la lower in the phenylhetonuric brain
than in the normal, and phanylpyruvlc acid is an affactive inhibitor of
osqrgan consumption in rat brain homogenats.

It may follow, tharaforo,

that tha aarly increased levels of phenylpyruvic acid in phenylketonuria
inhibit brain reap 1 rat ion at a critical tims In brain develt^ment, which
appears to be up to the age of six years when the rate of oxygen eonsuap*
tion should bo the greatest
Another suggested

ichaali

for neurological dafact cornea fr<

tha report of Faro, Sandler and Stacey on tryptophan metabolism. There
le a possibility that interference with serotonin synthesis by phenylalanine
or its derivatives may result in central nervous system defect.^ Although
there is much evidence which leads to the conclusion that serotonin plays
a role in brain functioning, tha exact role of tho aatne la still imper*
factly known.45 However, no relationship hotwsea 5*hydroxylndole levels
and intelligence has been found.54

15
An increased production of phonylethylamine, a decarboxylation
product of phenylalanine, has been found in patients with phenylketonuria.^3
Unlike the phenolic acids, phenylethylassine Is a phanaacoiogically active
substance which possesses properties much like amphetamine, although
weaker.

It is possible that increased production of such a pharmacologically

active substance may interfere with postnatal development of brain.^

?. tmtmm urn immmm
&*taction.

If phenylketonuria is diagnosed early in life, the

cental deficiency can be prevented by a restricted phenylalanine diet;
thus, early detection of this disease becomes one of the most Important
factors in preventing mental retardation.

Although

have questioned

the merits of screening programs, in the light of the cost of mentally
retarded patients in Institutions and the obvious significance to the
family to have a child saved from severe mental retardation, the effort
and the small cost appear well rewarded.
The use of 10 per cent ferric chloride is the oldest and the
best known detection test; however, it should be kept in mind that a
positive test is possible in a non-phenylketonuric child.25,3b Exports
have confirmed that negative tests are possible among phsnyIke tonur1c
patients whose serum phenylalanine level is lower than 15 mg* per cent^
and In some cases with higher serum levels.48 Also, the difference of
age when the urine test first shows a positive result in phenylketonuria
patients complicates the detection program.5^ Obviously a detection
titod should overcome these limitations.
Recently Dr. Robert Guthrie and coworkers developed and evaluated
a simplified blood phenylalanine•agar diffusion test by screening a large

I*
group of AMifttoi rotordatoo. This sinplo test it bassd os the foot chat
inhibition of growth of Baoillua anbtilla by bota*2*Thianylaiasiiiio in a
slop to aoaroaa^aaita agar aadiias ia apaeifleally provanted by addition
of phenylalanine, phanylpyruvic acid or prolina#^ This finding baa aada
poaaibla the simple diffnaian teat which eaploya aaall filter paper diaca
iapregnated with blood aanan on the agar surface. After overnight incu
bation. turbid rones of baetoriai growth surrounding the papar diaca are
observed end coopered with the control dloco properod from noxnel blood
to idiich bee boon eddod 2, 4, A, 12, and 20 eg. per emit of b*pl»ocylaleal«i
roepoctively. This permits blood ecoeya with the accuracy of plus or
minus 2 ng. per cent even among the new infante on the day of discharge
from the hospital.^ The infanta can ha teetad at 2 weeks of ago for
orlno phenylalanine end pbenyIke tone by the same phenylalanine-agar
diffusion toot, using filtor papor Impregnated with urine from a wat
diaper.**
In conj

tion with detection, it la of intoroot to noto the

variability of oorum phenylalanine levels ia normal

infante

especially in premature infante.****1**2
Treatment. The only

treatment for prevention of mental

impairment in phenyiketomirie patients at the present time is a
phenylalanine restricted diet. Bickel

in 1952 warn the

first to eaporimant with a restricted phenylalanine diet which resulted
in improvement of the clinical and mental condition of a two year old
girl.**** Since moat natural protein contains about 4 to 4 par cant of
phonylalanl

and there ia no protein with a low phenylalanine content

and a normal amount of other aaaontlal ami

aelde, it ia not poaalblo
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*0 achieve phenylalanine restriction with natural proteins*1 A casein
hydrolysate (X^ofenalac) which contains fat* carbohydrate* and sons added
eitaains and ainerals* with 95 per cent of the phenylalanine
has been prepared as the basis for a phenylalanine restricted diet* It
is proving to be an excellent substitute for ad Ik and other foods high
in protein* however, since any child needs note than a liquid forsula
to grow nomelly* a Serving system” of foods low in phenyUlanine has
dsvolopsd* using the sane principles as in the diabetic exchange
system*

i

phenylalanine cannot be
synthesised in the body* it is an aassntial amino acid and muat be
supplied in tbe diet.7® Bowever* tyrosine does exert a sparing affect
of 70 to 75 per cent upon phenylalanine requirements

if too

llttlo phenyleienine is given* lose of weight* vomiting* fever* lethargy
and Uatlaatnasa occur* and in severe cases a marked fiery rash or
exfoliative dermatitis develop*,®1*®®*78
The optimal phanylalanina requirement has bean definsd by Pains
and Bsia as "the point of minimal urinary total nitrogen end aipha^anixionitregen end the point at which a sharp riaa took piece in the previously
stable plasma phenylalanine level and urine phenylalanine phenylpyruvate
excretion*. ** Phenylalanine requirements for phonyIketonuric Infants
have

studiad by dlfforent groups with various results. Pains and

Bsia®® suggest 25 mg. par kg, of body weight for the 6 month old* Karla
and coworkers®7 state that 46 mg. par kg. of hedy weight is optimum*
while Acosta and Oonterwell® agree on 40 to 90 mg. per kg. of body weight.
According to Centexwall and coworkers1 phenylalanine requirements
decrease with age* which seems to be in agreement with other investigators
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as Pain* and 8ala also ausgaat only $ to IS xog. of phftaylalaniiia par
§§

kg. of body walgkt by tho tins a boy la 15 yaara old. ^

grotala raaulgaawnt. Altbough tba Katiooal Xaaaarch Gaimoll
iaroiiandad Olatary AUooaaoaa for proaola provida l.l go. ^ .5 go. par
pound of body ualgbc daring aha firat yaar of Ufa* tba actual protein
naada of both infanta ml adulta am debatable • aa It appaara that uora
to a

protein auat ha given to a phanylkatonuric child aa

child, alnee the protein hydrolyaate containa laaa nitrogen than the
original protein on a might baaia. 7ft
Caloric racuimaant. Caloric raftulrmanta, based

national

ftesearch Council ftaconnandad Olatary Allowances for a newborn, are 51
calories * 15 par pound of weight decreasing to AO calories par pound
of weight by the
of six. 28 Bowevar, because of the hyperactivity
of phanylkatonuric children who have net been treated early and alao
the aynthatle nature of the protein, Centerwail* and Irinblecowbe*2
recoranand

Increase of ^proxinately 12 por

in caloric Intake.

Woolf believes that by raising the ssrun glucosa level by giving
a fairly high proportion of calories as carbohydrate» the protein
aynthnala will ho

iterated which will result in rapid utilisation

of froo phenylalanine along with other anino acids. 7ft
Tvroslne reouircaent. Although tyroaina la not eoaaidarod aa
one of the essential amno acids, the

of a phanylkatonuric patient

with tyroaina deficiency on n diet low in phenylalanine has ham reported.
Increased phenylalanine seruut levels in this patient suggested tissue
breakdown due to tyrosine deficiency, this deficiency wee believed to
be caused by an absence of phenylalanine hydroxylase.*®
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U. PEOQUQSIS
Although m&ntml retardation can ha prevented with a rastricted
phenylaianina diet4 uniasss the treatment ia started relatively early
in life It b®Q,mma less effective. 19,35 Children started on diet before
6 months of age have an X*Q« significantly higher than those started
later in li£®J Among those phenylketonurics in institutions who were
placed on a restricted phenylalanine diet between the ages of 10 and 20
years, none stowed any significant clinical improvement even though
phenylpyruvic acid excretion was lowered.^ the mean Intelligence of
treated phonyiketoneric patients was wash higher than those of untreated
siblings, however, it
siblings.7

significantly lower than their unaffected

It must be boras in mind that although mental retardation

can be prevented by proper dietary treatment in early Infancy, the diet
may not afford complete protection, since many of these children do not
reach their normal intelligence potentials* IB
Hsia tentatively concluded that ^the metabolic disturbance
associated with the elevated concentration of phenylalanine in the
plasma, characteristic of phenylketonuria, interferes with normal
cerebral development rather than with the function of a normally developed
brain*. 33 If this is true, Horner believes that it should be possible
to terminate the diet at

time after the completion of brain

development without adverse effect.^ However, Centerwall and coworker©
state that the diet should be continued as long m there is significant
Improvement in mental development and behavior. 17

crntm in
Mmxm as FEocsmms
The methods of procedure employed «xe discussed

three

general classifications $
X* Selection of subjects*
XX* fie termination of optimal serum phenylalanine level and
the dietary pheoylalealoe required to maintain this level*
XXX* fivaluation of growth rate of treated pheayiketonurlc
joXedl

~tp>sa3i. Jemsst

e

sgLiarxei or so&iscrs

X.

the date utilieed in thle etudy mere secured from SO avsliable
msdleel records of phenylhetonuric petients et the Fedietrlc Clinic of
White Msmsrtit Modlcel Center end the Child Development Clinic of
Children*# Hospital in Lee Angeles, All petients studied mere current
cases and ages studied reused frsm § mouths to S peers*
For ths selection of subjects tbs following eriterie wero used:
1* tbs patient must

e phenylalanine •restricted

diet for a minimum of one year prior to tbe time these
records more reviewed or two years prior to tho terminate
ef dietary treatment*
X* the patient i

C have rocorde of clinie vieite twice or

mere yearly*
Xn addition, for tbe etudy to determine tbe optimal serum phenyl*
alanine level and diatary phenylalanine required to meinteie this lovel.
20

n
thm

bm41oi1

4otns

r«cor<jb» o£ —eh patient oust eontaixt felMi following opoeifie

(«) oonaB ptmoylnlonino ioonlOt (b) poychoiogicol ovnluatlcm

r«porto9 <c) 4i«tory 0Mmgrlglonle« intoko» mid (4) the ego when dietnry
treetaent wag InitloUp •texted.
For the eveltietion of growth rates of treated phenyikatoouric
ohiidren* the wedieal reeorde of each patient auet alee have the follow*
lag specific data in addition to the above criteria:

(a) protein intake,

(b) caloric intake, and (e) height end weight*
Of sixty aedical records reviewed, thirty were selected for the
steely to dotorwino the eptlwel eerm phenylalemiae level end twantytlnree
for the evaluation of growth rate of phenylkatossurle children* Other
reeorda reviewed were me need since they did not

the established

criteria*

Froceeeing of date, the

veiuee or eon® pneny texenin®

levels and dietacy phcnylelanlne intake for each patient were based on
a three-wenth period (i*o*, 0*0 aontha, 9 * 11

, 12 * 14

etc*)* This three«wKmth period tine lector wee arbitrarily chosen for
Uc echo of unifomity, gii

it was found to ho applicable to tho clinic

visit ochndalce of naot patients involved* The nean ean® phenylalanine
levels ware obtained by using all availahla laboratory reports for the
partlcnlar threa-wenth period end wore expreeaed as ng* per 100 nl* The
fhaaylalaniiia intalBe

also obtained for each three-wonth period

and expreeaed an ag* par pound of weUht•

22
o£ l.Q* or 0«Q. for m throo««oBth period

Tbft

wm obtoinad hf plotting tho actual X,Q* or

gainst the ago factor

on a croc# •actional graph.
Analra!*

4ata« fha data oara axtalysod in four catagoriaa

according to the ago uhan a phoxtylalanicwraatrictad diet van initially
started, fha agaa for tha groups wars 0-5 aoaths, h - 11 aonths,
12 • 23 aonths» and 24 aonths
Within each aga group, tha s«

phanylalanina levels aara

catagorisad into four classifications: •• lass than 3.9 ag. 1,
4 • 7.9

♦ X, 8 * 11.9 ag. X, and greater than 12.0

. X. The

change in X.Q. for each thraa-aonth period was classified into one of
tha above four groups according to the patient *» average sarua
phenylalanine level for that particular tbrac aonths. Aftsr X.Q. changes
of all patianto

classiflad under one of the four sarua

phenylalanine levels, a atan change in X.Q. for each thraa-aonth pariod
for each aga group was obtained.
The average phenylalanine intake for the age groups, 8 * 11
iths, 12 aonths - 2 years 11

ths, end 3*8 years, which would

aeintain the sarua phenylalanine level below 4 ag. per 100 al *» was
calculated using the asen phanylelaaias intake for each three-aonth
period of those patients with sarua phenylalanine levels below 4.0 ag.
par 100 al.
XXX. OQMPgXXtOK OF 18K GKOWTH 8dT88 OF TRK4TSD

vmamjmommtc mtumm with tbx establishso
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fxmm&tm. of

Tb® feilgiit and might obtained for each

patient ware plotted on the Iowa Grid every three ocmthe the firet 18
donthe of life and thereafter every elx months until ala years of age.
Each patlent*a caloric, protein, and phenylalanine intakes
were averaged for tfaxm*mmtb period® until 18 nontha of age and every
six months until six years of age* Nutritional intakes were expressed
as calories per pound, grata* of protein per pound, and mg, of phenylalanine
par pound of weight.
Analysis of data,

Using the Iowa Grid, the height for each

patient was classified as being above the mean, between the mean and
the man minus one standard deviation, or below the mean minus one
standard deviation; whereas, the weight was classified as being above
the mean, between the mean .and the 18th percentile, or below the 16th
percentile.

Using the above data, the growth rate of phenylketonuria

children was compared with the established norm, Also, the growth rates
of those patients who were started on dietary treatment during the first
six months of life <5 patients) were compared to those who were started
on the diet after six months of age.
For comparison of nutritional intake of those with normal growth
rate and those with subnormal growth rate, ail those patients with heights
above the mean minus one standard deviation and weights above th® 16th
percentile were considered to have normal growth rates. The mean
values for caloric, protein, and phenylalanine intakes were calculated
for each 3 or 6 month period for all patients In each group in order to
compare their nutritional intake with the 1963 Recommended Dietary
Allowances of the Food and Nutrition Board of the National Research
Council,

24

datera&TWtiopa. The

serum plsenyielanlcte levels

e£ these with nerstel growth rets end those with subnormal growth rate
were also compared for each of the four groups of patients according to
the age when a phenylalanine-restricted diet was initially started*

OMPYSt XV

fbtt r««ult0

discussed under tloree separate headings! the

deteralnatien of the serial phenylalanlxte for optleel increase in
inteiUgence9 the dletarp pheaylaianina required to neintaln serum
phanylaimiins heloir 4*0 eg. per 100 ml*t and the comparison of the
groetlt rates of phengrlketomirie children with the established norm.
Xa order to hatter understand the relationship of nerleoe data
for each patient,

eensa phenylalanine values for different

periods, selected nutritional data, percentile of height and Height,
aa mail m the actual l.Q* values ere gr^hically ahoea in figures

m QfTXMaL XXC3BXASS Id IMrELLXGXgCE
of X.0« for each 3 month period at different
aero* phenylalanine lev®Is <0 * 3.f «g.l, 4 - 3*0 ag,X» g . ll.o
end greeter than 12.0 ng.X) ere plotted egainat the age fester in fipuree
3*4,

24*29* la these figures, the nuabers

the right sale

represent the change in intelligence ter a 3 month period as evaluated
by using such psychological testa aa Geseli and Stanferd*2iaat* Sach
mater represents the points of X*Q« increese or doeresse* For oxaqpio,
an ineroaoo of X«Q* from 75 to 40 uiU be 4*3, uhsroos e docreese of l*Q*
frma 40 to 73 will bo *5* Soch figure represents o specific ego in
25
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relation to the time phenylalanine restriction wee initiated; that
la — Figure 3 represents those patients started on diet between l
through 5 aostthe of age. Figure 4 represents those started on diet
0 through U months of age, Figure 3 those patients started
between 11 through 33

diet

iths of ego, end Figure 4 those e terted on diet

after 24 smaths of age*
the average initial X*Q, of all thesa patients starting on diet
0 through S months of age wee 89, followed by a alight average deereeee
to 88 during the 2 years on treatment* However, when serum phenylalanine
levels were observed, there appeared to be considerable difference in
maintenance of I«Q« the 2 patients whose sense phenylalanine levels
ranged from 0 » 3*9

•1 started with an average X,Q* of 80 and In*

craasad to 87 * an increase of 8*81*

Xn the 3 patients whose serum

phenylalanine levels ranged from 4 • 7*9 mg.Z there wee an average
Initial X.Q« of 93 with a dacraaae to 83 (12*6%) following two years of
treatment* the 1 patient whose ee:

phenylalanine levels wars greater

then 8 mg* % had an Initial I.Q. of 90 and a final I.Q. of 66, a 26*6%
decrease* the greatest increase of X.Q. occurred in this group when
serum phenylalanine levels were below 4 mg*%* there were decreases in
X.Q. in all patients whose serum phenylalanine levels were greeter than
4 mg.%*

(See Figures 3-6, pages 26-29, end table X, page 31.)
the 6 children who started on dietary traatmsat between the ages

of 6 through 11 months had an averaga X.Q* of 60 initially* After 1%
years

dietary traatmant, the average X.Q. was 73* like l patient

whose serum phenylalanine lave is remained below 4 mg.% had an initial
X.Q* of 84 asid a final X.Q. of 97* This

inersssa of 13%* the

4 patients whose serum phenylalanine levels rangsd from 4 - 7.9 mg.%
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TABUS l
THE RELATIONSHIP OP INITIAL Aim FIHAL I.Q. TO VAHYING SEBUM
PHENYLALAKXNE LEVELS A23> ACE OF BDGIimiNG
DIETARY TREATHENT

Munber
of
Patients

Asa Started
on
Diet

Average Serum
Phenylalanine
Lavela

Average Average
Initial Final
I.Q*
I.Q.

Percentage
Change

2

0 through 5 months

0 * 3.9 mg* %

80

87

8.8X increase

3

0 through 5

4 - 7.9 mg. %

95

83

12.6Z decrease

1

0 through 5 months

90

66

26.SX decrease

1

6 through 11 months 0 - 3*9 mg* %

84

97

15.0X increase

4

6 through 11 months 4 - 7.9 mg. %

53

66

24.51 increase

1

6 through 11 months

61

77

26.2% increase

tths

8 mg* t

8 mg. X

0

12 through 23 months 0 - 3.9 mg. X

6

12 through 23 months 4 - 7.9 mg. X

5

12 through 23 months

2

over 24 months

3

over 24 months

2

over 24 months

mm

49

72

46.9% increase

50

62

24.OX ineroase

0 m 3.9 mg. X

40

53

32.5X Increase

4 - 7.9

33

50

51.5X increase

57

64

12.3X increase

8

. X

8 mg. X

• X
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imA m initial avasaga X,Q» of 53 and a final average l.Q. of
incraaee of 24.5X. The 1 child whose sense phenylalanine levels wars
greater than 8 ag.X had an initial l.Q, of dl and a final l.Q. of 77,
an increase of 26.2X* The greatest increase of l.Q. occurred in the
1 child whose senas phenylalanine levels were greater than 8 ag*X*
However* there
levels*

its substantial increases at all serum phenylalanine

(See Figures 3 * 6* pages 28*29* and Table l* page 31.)

The average initial 1«Q, of the 11 children started on dietary
treatment between 12 months to 23 months of age was 51 and there was
an increase to 85 during the following 2 years while on dietary treat*
* Hone of the patients in this ags group had serum phenylalanine
levels below 8 ag.X.

In the 8 patients whose serum phenylalanine levels

ranged from 4 * 7,9 mg,X* there wag an Initial averaga l.Q, of 49 and a
final averaga I,Q, of 72* an incraass of 48.9X,

In the 5 patients whose

serum phenylalanine levels wars greater then 8 ag.X* the average initial
I,Q, was 50 and the average final l.Q. was 82* an incraass of 24X. The
greatest increase of l.Q. occurred in those children whose serum
phenylalanine levels ranged from 4 * 7,9

(See Figures 3*8*

pages 28*29* and Table 1* page 31*)
Among the 7 patients in the group who wore started on dietary traat*
moot after 24 months of age* the initial average l.Q. had dropped to 42
and increased only to 53 even after 2 years of dietary treatment. Two
patients maintained se:
average initial l.Q,

phonylalanins levels below 4 mg.X. Their
40 Mid their average final l.Q, was 53* mi

increase of 32.SX. The 3 children whose serum phenylalanine levels
ranged from 4 • 7.9 mg.X had mi averaga Initial l.Q. of 33 and an
averaga final l.Q. of 50* an increase of 51.SX. The 2 children whose

33
a^nnsj phanyialoxiin® lewis were greater thm 8 mg.% had an average
initial I*Q. o£ 37 and an average final X.Q. of $4, an increase of
12*3%.

In this age group, the greatest increase of intelligence

occurred in those children whose serum phenylalanine levels ranged from
4-7.9 tag.Z.

(See Figures 3-6, pages 26-29, and Table l, page 31.)

It should be noted (Table X) that only those children started on
diet before 12 months of age and whose serum phenylalanine levels were
maintained below 4 mg.Z had a final I.Q* in the normal range.

Those

children starting on diet at birth whose serum phenylalanine levels
were greater than 4 mg.X had a decrease in I.Q. This data would suggest
that serum phenylalanine levels above 4 mg.X are particularly harmful
during the first year of life.
II. THE UIETAET FHEICSRLALAHIHE EEQ1IIEEB TO miMMM
THE SERUM PHEHYLA3LANIHB LEVEL BELOW 4.0 US. FEE 100 ML.
Since it appeared that there was the greatest increase of intelli
gence In those children started on diet at birth when serum phenylalanine
levels were kept below 4.0 mg. per 100 ml • * the phenylalanine intakes of
all those children with serum phenylalanine levels below 4.0 mg. par 100
ml. were averaged. The results are presented in Table II, page 34, along
with the recoaraendad phenylalanine intake by Centerwali and coworkers.*
In comparing these two sets of values according to the ages,
6 - U months, i year - 2 years 11 months, and 3-6 years, there appears
to be no significant difference between them.

m. ammisoH

of the growth rates of

FHSmXETOmiEIC CHILDREN’ WITH THE ESTABLISHED TOMS
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TABLE II
PHENYLALANINE RECOMMENDED FOR VARIOUS AGE GROUPS

Age

Normal

Phenylalanine - Mgm./lb.
Phenylketonuric^
Phenylketonuria^

1-9 months
0-3 months

41

20 - 22
6-11 months

4-12 months

20.7

18 - 20

1 year2 years 11 months*

13.9

16 - 18

3-6 years*

14.1

10 - 16

* No research done on requirements for this age
1 Mean dietary intake of those with serum phenylalanine below 4.0 sig.X
2 RecoEiaended amounts by Centerwall^-
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In evaluating 23 phenylketosmric

patients, they speared to foe shorter when coiapared to the established
norm:

that is to say the height growth curve for the majority of these

patient® fell below the mean minus one standard deviation on the Iowa
Grid,

However, their wight growth curve did not parallel their height

as portrayed in Figure 7, page 36,

In comparing their weight mid height

growth curves, 65.2% of the patients were below the lower limit of the
normal height growth curve (mean minus one standard deviation); whereas,
43,5% were below the lower limit of the normal weight growth curve (the
16th percentile), there were 21,7% with weight above the mean as
compared to 4,4% with height above the mean. The remaining patients,
34.8% for weight comparison, and 30.4% for height comparison, fell be
tween the mean and the lower limits of growth curves.
It has been stated previously that pheaylketonuric children
tend to be smaller than normal children.^5 The phenylketonuria children
participating in this study were shorter than normal children.
Figure 8, page 37, gives a comparison of the growth rates of
those patients started on dietary treatment during the first 6 months
of life and those started later in life. There were only 5 (21.7%) out
of 23 patients who had been on a phenylalanine-restricted diet fro® the
first 6 months of life.

Four, or 80%, of these 5 patients had weight

below the 16th percentile and only one, or 20%, was above the 16th
percentile. Of those patients started on treatment after 8 months of
age, there were 33.3% whose weight was below the 16th percentile,
39.9% between the 16th percentile and the mean, and 27.8% above the mean.
The height of all 5 patients started on diet before 6 month® of age was
below the mean minus one standard deviation; whereas, for those patient®
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started on diet later is life, 55.5% ware below the mean minus on®
standard deviation*
^valuation gf Nutritional XntMm*

Unexpected results were ob

tained while comparing the mean nutritional intake of phenylketonuria
children with normal and subnormal growth rates • Contrary to what was
ejected, as seen in Figure 9, page 38, the mean caloric» protein, and
phenylalanine intakes in the different age groups of those patients
with subnormal growth rates were significantly higher than those with
noma! growth rates. The protein intake of both groups was above the
1963 Recommended ©ietary Allowances of the National Research Council;
however, the protein intake of those with subnormal growth rates was
considerably higher* The caloric intake of those with subnormal growth
rates was considerably above the Recommended Dietary Allowances; whereas»
the caloric intake of those with normal growth rates fell below the Reconmended Dietary Allowances between the ages of l year and 3 months and
3 years.
It should be kept in mind that the recommended allowances “are
Intended to cover individual variations among most normal persons as
they live in the United States under usual envin

intal stresses'*.22

In an effort to ascertain seme other factor besides nutritional
Intake which may have had an effect on growth rates of these phenylkelonuric children, the average serum phenylalanine levels at different
ages of those with normal and subnormal growth rate were compared.

Tm

results are shown graphically in Figures 10 - 13, pages 41-44, accord
ing to the ages when the dietary treatment was Initially started.
should be noted that those children starting on diet 0-5 months.

It
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0 * ll siontha, mad ovmr 23 acmths with wxba&mml growth ratos had
•iightiy lamx arnwm plumy lalaztine lava la during tha early acmths of
esaatnemt than did those children with normal growth rates*
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CHAPTER V
simsary

Am ooncLmim

A study to dettraina the serum phenylalauina level which would
result in greatest Increase or maintenance of intelligence was carried
out.

Thirty phenylketonuria patients under dietary treatment were

involved.

From calculations based on two factors, namely, the

m

serum phenylalanine levels and the changes of I.Q. for each 3 month
period, it appeared that the greatest increase or maintenance of I.Q.
occurred in those children starting on diet at birth with serum phenyl*
alanine levels below 4.0 mg. per 100 ml.

The changes in I.Q. of 12

groups according to the ages when diet was Initially started and average
serum phenylalanine levels are as follows:
Slumber
of
Patients

Age Started
on
Piet

Average Serum
Phenylalanine
Levels

Average Average
Initial
Final
hQs^

Percentage

—asms

2

0 through S months

0 • 3.9 mg, %

80

87

8.8% increase

3

0 through 5 months

4 - 7.9 mg. %

95

S3

12.6% decrease

l

0 through 5 months

90

66

26.6% decrease

l

6 through ll months

0 * 3.9 rag. %

84

97

15.0% increase

4

6 through 11 months

4 * 7.9 mg. %

53

66

24.5% increase

l

6 through 11 months

61

77

26.2% increase

0

12 through 23 months

0 - 3.9 rag. %

6

12 through 23 months

4 * 7.9 mg. X

49

72

46.9% increase

5

12 through 23 months

50

62

24.0% increase

8 mg. X

8 mg. %

8 mg, %
45

46
2

ovar 24

ths

0 * 3.9 «g« %

40

S3

32.3% increase

3

over 24 nenche

4 - 7.9 eg. %

33

50

51*5% increase

2

over 24 months

57

64

12.3% increase

0 eg. %

Xn coopering the growth rates of 23 patients with normal growth
rates using the Iowa Grig, it was found diet the weight growth curve of
43.5% of the patients was helot# the norm, whereas the height growth curve
of 65.2% of the patients was below the norm. When the patients who were
started on dietary treatment before the age of 6

ifcha (5 patients) were

compared with those who were started on diet after the ege of 6 months
<18 patients), it was found thst in the former group there wee 80% whose
weight and 100% whosa height was below the norm. In the letter group
there were 33.3% with weight and 55.5% with height below the norm.
Contrary to what was expected, the caloric, protain, and phenyl*
alanine intakes of those with subnormal growth rates were somewhat
higher than titans with normal growth ratss. The protein intake of both
groups was above national Research Council Recommended Dietary Allowances.
Thers was no significant difference in the serum phenylalanine levels
of the two groups.

It appeared that there might he a positive correlation

between early lew serum phenylalanine levels end subnormal growth rates.
It was not posslbls to draw any definite conclusion from the
growth study, since many factors which might influents growth rataa
wars not considered.
The following recommendations were made for further research baaed
on the results and limitations of this study:
1* The use of better controlled groups in order to obtain
data at rsgular intervals.

r w

47
2. The use of 3 day nutritional histories instead of
recall nutritional histories for accuracy*
3* The re-evaluation of growth rates of phenyIketonuric
patients, taking into consideration hereditary factor#
by obtaining the data on physical status of carrier
parents and siblings and non-carrier siblings*
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Data fro® thirty medical records of phenylketonuria children
under treatment were investigated to determine at which serum phenyl
alanine level (0-3.9 mg. %, 4-7.9 mg, %$ 8-11,9 mg. %, greater than
12 mg. X) there would be the greatest increase in intelligence.

The

children involved in the study were divided into the following groups
according to the age dietary treatment was Initiated:

0 through 5

months, 6 through 11 months, 12 through 23 months, and over 2 years of
age.
Among 6 patients who were placed on the diet during the first
5 months of life, it appears that the optimal serum phenylalanine level
to maintain I.Q. was between 0-3,9 mg.X.

The average I.Q. at the

beginning of treatment in this age group was 89, followed by a slight
decrease during the next two years to 85.

There were 6 children who

were started on diet between the ages of 8 months through 11 months.
Although it appeared that a gradual increase in I.Q. resulted even with
an elevation of serum phenylalanine levels to 12 mg.X, a definite con
clusion could not be made for this group since there was much missing
data.

The initial average I.Q* in this group was 60 and it increased to

75 after 1% years of treatment.

This was an average increase of 25%.

The average initial I.Q. of the 11 patients who started on diet
between 12 through 23 months of age was 51.

During the following 2

years, the average I.Q. of this group increased to 65, an increase of
27X.

Among this group, the greatest I.Q. increase was obtained in

those patients whose serum phenylalanine levels were below 4.0 mg.X.
In the 7 patients who were started on diet after the age of 24 months,
x

the average initial X.Q. was 42 and it increased to 53 during the next
2 years, an increase of 26%.

The greatest increase occurred in those

patients whose serum phenylalanine levels were below 8.0 tag.%.
Since it appeared that serum phenylalanine levels below 4.0 mg.%
produced the greatest increase in X.Q. in the preceding 4 groups, the
phenylalanine intake of these groups were evaluated.

The average

phenylalanine intake was found to be comparable to that recoiQBaended
by Centerwall and coworkers.
The growth study of 23 treated phenylketonuria children in
dicated that there was a greater percentage of patients with height
growth curves below the norm as compared with their weight growth curve
as ascertained by Iowa's Grid.

Xn comparing the growth rates of those

started on dietary treatment before the age of 6 months with those started
after 6 months of age, it was found that greater percentage of those
started on diet before 6 months of age had subnormal growth rates.
When the caloric» protein, and phenylalanine intakes of those
children with normal and subnormal growth rates were compared. It was
found that significantly larger amounts of all three nutrients were
consumed by the children with subnormal growth rates than those with
normal growth rates.

Xn both groups, protein and calories were present

in amounts greater than those recommended by the national Research Council.
No definite conclusion can be made from this part of the study at this
time since many factors which may influence the growth rate of a child
were not considered.
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